A rendering of Resilience's biomanufacturing site in Marlborough, MA that has been purchased by Oxford Properties Group (CNW Group/Oxford Properties Group Inc.)
February 17, 2023 03:21 PM EST
Deals
Pharma
Manufacturing

Ox­ford Prop­er­ties Group pur­chas­es Re­silience man­u­fac­tur­ing site for $125M

Tyler Patchen

News Reporter

The in­ter­na­tion­al re­al es­tate com­pa­ny Ox­ford Prop­er­ties Group has pur­chased a man­u­fac­tur­ing fa­cil­i­ty in the Boston sub­urbs.

Ac­cord­ing to Ox­ford, it has pur­chased a 120 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

Ther­mo Fish­er buck­les up for US-Chi­na trade war, bud­gets $2B to ease im­pact

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times